Robinson-Cohen Cassianne, Zelnick Leila R, Hoofnagle Andrew N, Lutsey Pamela L, Burke Gregory, Michos Erin D, Shea Steven J C, Tracy Russell, Siscovick David S, Psaty Bruce, Kestenbaum Bryan, de Boer Ian H
Kidney Research Institute, Division of Nephrology, Department of Medicine, University of Washington, Seattle, Washington 98195.
Department of Laboratory Medicine, University of Washington, Seattle, Washington 98195.
J Clin Endocrinol Metab. 2017 Aug 1;102(8):3075-3084. doi: 10.1210/jc.2017-00296.
Low 25-hydroxyvitamin D [25(OH)D] is associated with coronary heart disease (CHD) in people who are white and Chinese but not black or Hispanic. Vitamin D binding globulin (VDBG) avidly binds 25(OH)D, reducing its bioavailability, and differs in isoform and concentration by race.
Evaluate associations of VDBG with CHD and whether accounting for VDBG or estimating bioavailable 25(OH)D explains the heterogeneity of the association of 25(OH)D with CHD.
We conducted a case-cohort study within the Multi-Ethnic Study of Atherosclerosis. Participants with an incident CHD event over 12 years of follow-up (n = 538) and a randomly assigned subcohort (n = 999) were included. We measured baseline 25(OH)D, VDBG, and isoforms using mass spectrometry and estimated bioavailable 25(OH)D from published equations.
VDBG was associated with an increased risk of CHD [hazard ratio, 1.77 (95% confidence interval, 1.46 to 2.14) per standard deviation increment, P < 0.0001], without evidence of heterogeneity by race or isoform (each P for interaction > 0.1). Low total 25(OH)D was differentially associated with CHD events, by race, with or without adjustment for VDBG (P for interaction = 0.04 or 0.05, respectively). Associations of 25(OH)D with CHD were strengthened with adjustment for VDBG among participants who were white or Chinese, and bioavailable 25(OH)D was associated with CHD events only among white participants.
High VDBG concentration was associated with CHD events in all racial and ethnic groups. Incorporation of VDBG strengthened existing associations of 25(OH)D with CHD but did not explain racial heterogeneity in associations of 25(OH)D with CHD.
低水平的25-羟基维生素D[25(OH)D]与白人和中国人的冠心病(CHD)相关,但与黑人和西班牙裔无关。维生素D结合球蛋白(VDBG)能紧密结合25(OH)D,降低其生物利用度,且其异构体和浓度因种族而异。
评估VDBG与CHD的关联,以及考虑VDBG或估计生物可利用的25(OH)D是否能解释25(OH)D与CHD关联的异质性。
我们在动脉粥样硬化多民族研究中进行了一项病例队列研究。纳入了在12年随访期间发生CHD事件的参与者(n = 538)和一个随机分配的亚队列(n = 999)。我们使用质谱法测量了基线25(OH)D、VDBG及其异构体,并根据已发表的公式估计生物可利用的25(OH)D。
VDBG与CHD风险增加相关[每标准差增加的风险比为1.77(95%置信区间为1.46至2.14),P < 0.0001],没有种族或异构体异质性的证据(交互作用的P值均> 0.1)。无论是否调整VDBG,总25(OH)D水平低与CHD事件的关联因种族而异(交互作用的P值分别为0.04或0.05)。在白人和中国人参与者中,调整VDBG后25(OH)D与CHD的关联增强,且仅在白人参与者中生物可利用的25(OH)D与CHD事件相关。
高VDBG浓度与所有种族和族裔群体的CHD事件相关。纳入VDBG增强了25(OH)D与CHD的现有关联,但并未解释25(OH)D与CHD关联中的种族异质性。